Can you provide the average price target for PAVMED INC stock?
8 analysts have analysed PAVM and the average price target is 321.3 USD. This implies a price increase of 3050% is expected in the next year compared to the current price of 10.2.
PAVMED INC (PAVM) Forecast, Price Target & Analyst Ratings
NASDAQ:PAVM • US70387R5028
Current stock price
10.2 USD
-0.2 (-1.92%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PAVMED INC (PAVM).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Mar 23, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$5.51
- Revenue Estimate
- 51K
Price Target Details & History
Consensus Price Target and Range
Mean target
$321.30
Upside
+ 3,050.00%
From current price of $10.20 to mean target of $321.30, Based on 8 analyst forecasts
Low
$121.20
Median
$321.30
High
$535.50
Price Target Revisions
1 Month
0.00%
3 Months
2,525.00%
Price Target Summary
8 Wall Street analysts provided a forecast for the next 12 months for PAVM. The average price target is 321.3 USD. This implies a price increase of 3050% is expected in the next year compared to the current price of 10.2.
The average price target has been revised upward by 2525% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.50%
PAVM was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about PAVM.
In the previous month the buy percentage consensus was at a similar level.
PAVM was analyzed by 8 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-12-10 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-10-06 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-06-06 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-04-21 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-12-09 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-09-10 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2023-08-18 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2023-01-20 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2023-01-18 | Lake Street | Maintains | Buy |
| 2022-08-17 | Lake Street | Maintains | Buy |
| 2021-03-30 | Cantor Fitzgerald | Initiate | Overweight |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Mar 23, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$5.51
- Revenue Estimate
- 51K
- Revenue Q2Q
- 410.00%
- EPS Q2Q
- -1,999.31%
- Number of Analysts
- 4
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
-2,900.00%
Next Earnings Summary
PAVM is expected to report earnings on 3/23/2026. The consensus EPS estimate for the next earnings is -5.51 USD and the consensus revenue estimate is 51.00K USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 380K -24.00% | 2.452M 545.26% | 2.995M 22.15% | 90.78K -96.97% | 499.8K 450.56% | 187.27M 37,368.99% | 243.37M 29.96% | 311.51M 28.00% | 389.44M 25.02% | |
| EBITDA YoY % growth | -88.47M -63.35% | -65.863M 25.55% | -43.289M 34.27% | -3.06M 92.93% | -18.768M -513.33% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -90.93M -67.18% | -68.795M 24.34% | -44.487M 35.33% | -22.209M 50.08% | -24.179M -8.87% | 21.318M 188.17% | 47.226M 121.53% | 79.152M 67.60% | 118.32M 49.48% | |
| Operating Margin | -23,928.95% | -2,805.67% | -1,485.38% | -24,465.17% | -4,837.65% | 11.38% | 19.41% | 25.41% | 30.38% | |
| EPS YoY % growth | -15.15 -62.90% | -9.16 39.54% | -2.08 77.29% | -3.67 -76.54% | -24.48 -566.67% | N/A | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -5.51 -1,999.31% | -6.43 -163.00% | -7.96 64.16% | -5.20 40.21% | -0.16 97.04% |
| Revenue Q2Q % growth | 51K 410.00% | 75.48K 843.50% | 99.96K 1,566.00% | 124.44K 2,388.80% | 199.92K 292.00% |
| EBITDA Q2Q % growth | -4.794M -20.18% | -4.692M 13.16% | -4.692M -0.90% | -4.692M 1.37% | -4.692M 2.13% |
| EBIT Q2Q % growth | -6.039M -16.43% | -6.256M -14.88% | -6.148M -30.38% | -5.921M -22.23% | -5.803M 3.91% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
268.29%
Revenue Next 5 Year
142.05%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
PAVMED INC / PAVM Forecast FAQ
When does PAVMED INC (PAVM) report earnings?
PAVMED INC (PAVM) will report earnings on 2026-03-23, after the market close.
Can you provide the consensus estimates for PAVMED INC next earnings?
The consensus EPS estimate for the next earnings of PAVMED INC (PAVM) is -5.51 USD and the consensus revenue estimate is 51.00K USD.
Can you provide the analyst count for PAVMED INC stock?
The number of analysts covering PAVMED INC (PAVM) is 8.